Evaluation of Negative Symptoms and Cognitive Function After Administration of Antipsychotics in Healthy Volunteer

• Status: Completed
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the study is to investigate the negative symptoms and cognitive function after administration of antipsychotics in healthy volunteer.

• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Chonbuk National University Hospital
• Treatments: Amisulpride; Antipsychotic Agents; Aripiprazole; Haloperidol; Haloperidol decanoate; Risperidone; Sulpiride; Sultopride

Criteria

Inclusion Criteria:

• Aged 18-38 years and meet no DSM-IV diagnostic criteria as assessed by using the Structured Clinical Interview for DSM-IV, research version.

Exclusion Criteria:

• 1) anyone who participated in other clinical trials within 30 days from the start of this clinical trial or is currently participating in one,

• 2) anyone who has progressive disease or in unstable medical condition unfit for the trial,

• 3) anyone who has been diagnosed in psychiatric terms in the past, depends on psychotropic substance, or has overdosed or depended on the substance or alcohol (except for coffee or tobacco) within 1 month from the trial start,

• 4) anyone who is suicidal or highly probable of suicides, or

• 5) anyone who has test results considered clinically meaningful